Cargando…
Severe pneumonia with formation of a pulmonary cavity associated with long-term rituximab therapy in multiple sclerosis
Nowadays B-cell depletion via anti-CD20 antibodies is commonly applied in the treatment of multiple sclerosis (MS). Yet, not much is known about infection risks associated with long-term B-cell depletion in the specific context of MS. We present the case of a 45-year-old male patient who developed s...
Autores principales: | Schwake, Carolin, Gold, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650061/ https://www.ncbi.nlm.nih.gov/pubmed/33324932 http://dx.doi.org/10.1186/s42466-020-00074-0 |
Ejemplares similares
-
Experience with long-term rituximab use in a multiple sclerosis clinic
por: Barra, Megan E, et al.
Publicado: (2016) -
Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis
por: Filikci, Zuhal, et al.
Publicado: (2022) -
Multiple sclerosis, rituximab, and COVID‐19
por: Langer‐Gould, Annette, et al.
Publicado: (2021) -
Effects of treatment with rituximab on microcirculation in patients with long-term systemic sclerosis
por: Vilela, Verônica Silva, et al.
Publicado: (2018) -
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
por: Kogel, Ann-Kathrin, et al.
Publicado: (2021)